Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
Clinical trial NCT00610792 · WITHDRAWN
Trial details
- NCT number
- NCT00610792
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-09-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.